Ventricular rate control using a novel vagus nerve stimulating system in a dog with chronic atrial fibrillation

Journal of Veterinary Cardiology

Volumn 10, Issue 2, 2008, Pages 147-154

  Ohad, Dan G ^a   Sinai, Yitzhak ^b   Zaretsky, Asaph ^c   Shofti, Rona ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BioControl Medical Ltd   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Bordeaux dog; Canine; Dogue de Bordeaux; Ultrasound guided valvuloplasty; Vagal stimulation

Indexed keywords

ATENOLOL; DIGOXIN; DIGOXIN ZORI; DISOTHIAZIDE 25; ENALADEX; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ANIMAL EUTHANASIA; ARTICLE; CONGESTIVE HEART FAILURE; DOG; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ECHOGRAPHY; EVENING DOSAGE; HEART ATRIUM FIBRILLATION; HEART RATE; MALE; MORNING DOSAGE; NONHUMAN; POSTOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME; TRICUSPID VALVE DISEASE; VAGUS NERVE STIMULATION;

ANIMALS; ATRIAL FIBRILLATION; BALLOON DILATATION; DOGS; ELECTRIC STIMULATION; FATAL OUTCOME; HEART FAILURE; MALE; VAGUS NERVE;

CANIS FAMILIARIS;

EID: 57049161910     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2008.09.004     Document Type: Article

References (32)

1. Kittleson M.D., and Kienle R.D. Diagnosis and treatment of arrhythmias. In: Kittleson M.D., and Kienle R.D. (Eds). Small animal cardiovascular medicine (1998), Mosby, St. Louis, MO 449-494
2. Menaut P., Bélanger M.C., Beauchamp G., Ponzio N.M., and Moïse N.S. Atrial fibrillation in dogs with and without structural or functional cardiac disease: a retrospective study of 109 cases. J Vet Cardiol 7 (2005) 75-83
3. Gelzer A.R., and Kraus M.S. Management of atrial fibrillation. Vet Clin North Am Small Anim Pract 34 (2004) 1127-1144
4. Bonagura J.D., and Ware W.A. Atrial fibrillation in the dog: clinical findings in 81 cases. J Am Anim Hosp Assoc 22 (1986) 111-120
5. Stokhof A.A., and Van den Brom W.E. Survival time in dogs with spontaneous atrial fibrillation related to scintigraphically measured cardiac performance. Vet Q 12 (1990) 161-165
6. Khasnis A., Jongnarangsin K., Abela G., Veerareddy S., Reddy V., and Thakur R. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol 28 (2005) 710-721
7. Bright J.M., Martin J.M., and Mama K. Cardioversion of dogs with atrial fibrillation. J Vet Cardiol 2 (2005) 85-96
8. McGurrin M.K.J., Physick-Sheard P.W., and Kenney D.G. How to perform transvenous electrical cardioversion in horses with atrial fibrillation. J Vet Cardiol 7 (2005) 109-119
9. AFFIRM Investigators. A comparison of rate and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
10. Saunders A.B., Miller M.W., Gordon S.G., and Van De Wiele C.M. Oral amiodarone therapy in dogs with atrial fibrillation. J Vet Intern Med 20 (2006) 921-926
11. Moïse N.S., Pariaut R., Gelzer A.R.M., Kraus M.S., and Jung S.W. Cardioversion of vagally associated atrial fibrillation with lidocaine in two dogs. J Vet Cardiol 7 (2005) 143-148
12. Lerman B.B., Ellenbogen K.A., Kadish A., Platia E., Stein K.M., Markowitz S.M., Mittal S., Slotwiner D.J., Scheiner M., Iwai S., Belardinelli L., Jerling M., Shreeniwas R., and Wolff A.A. Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans. J Cardiovasc Pharmacol Ther 6 (2001) 237-245
13. Wood M.A. Trials of pacing to control ventricular rate during atrial fibrillation. J Interv Card Electrophysiol 10 Suppl. 1 (2004) 63-70
14. McGurrin M.K.J., Physick-Sheard P.W., Kenney D.G., Kerr C., and Hanna W.J. Transvenous electrical cardioversion of equine atrial fibrillation: technical considerations. J Vet Intern Med 19 (2005) 695-702
15. Poole-Wilson P.A., and Opie L.H. Digitalis, acute inotropes, and inotropic dilators. Acute and chronic heart failure. In: Opie L.H., and Gersh B.J. (Eds). Drugs for the heart. 6th ed. (2005), Elsevier Saunders, Philadelphia, PA 149-183
16. Aronow W.S. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure. Cardiol Rev 14 (2006) 108-124
17. Braunwald E., Brockenbrough E.C., and Frye R.L. Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis. Circulation 26 (1962) 166-173
18. Wood M.A., Brown-Mahoney C., Kay G.N., and Ellenbogen K.A. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 101 (2000) 1138-1144
19. European Heart Rhythm Association, Heart Rhythm Society, Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Zamorano J.L., American College of Cardiology, American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, and Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary. J Am Coll Cardiol 48 (2006) 854-906
20. Bunch T.J., Mahapatra S., Bruce G.K., Johnson S.B., Miller D.V., Horne B.D., Wang X.L., Lee H.C., Caplice N.M., and Packer D.L. Impact of transforming growth factor-beta 1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation 113 (2006) 2485-2494
21. Thambo J.B., Bordachar P., Garrigue S., Lafitte S., Sanders P., Reuter S., Girardot R., Crepin D., Reant P., Roudaut R., Jaïs P., Haïssaguerre M., Clementy J., and Jimenez M. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation 110 (2004) 3766-3772
22. Tops L.F., Schalij M.J., Holman E.R., van Erven L., van der Wall E.E., and Bax J.J. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 48 (2006) 1642-1648
23. Wright K.N., Bright J.M., Cox Jr. J.W., and McCracken M.D. Transcatheter modification of the atrioventricular node in dogs, using radiofrequency energy. Am J Vet Res 57 (1996) 229-235
24. Zhuang S., Zhang Y., Mowrey K.A., Li J., Tabata T., Wallick D.W., Popović Z.B., Grimm R.A., Natale A., and Mazgalev T.N. Ventricular rate control by selective vagal stimulation is superior to rhythm regularization by atrioventricular nodal ablation and pacing during atrial fibrillation. Circulation 106 (2002) 1853-1858
25. Nattel S., Khairy P., Roy D., Thibault B., Guerra P., Talajic M., and Dubuc M. New approaches to atrial fibrillation management. A critical review of a rapidly evolving field. Drugs 62 (2002) 2377-2397
26. Labiner D.M., and Ahern G.L. Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. Acta Neurol Scand 115 (2007) 23-33
27. Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 18 (2001) 415-418
28. Ramsay R.E., Uthman B.M., Augustinsson L.E., Upton A.R., Naritoku D., Willis J., Treig T., Barolat G., and Wernicke J.F. Vagus nerve stimulation for treatment of partial seizures: II. Safety, side effects, and tolerability. First international vagus nerve stimulation study group. Epilepsia 35 (1994) 627-636
29. Bijwadia J.S., Hoch R.C., and Dexter D.D. Identification and treatment of bronchoconstriction induced by a vagus nerve stimulator employed for management of seizure disorder. Chest 127 (2005) 401-402
30. Ronkainen E., Korpelainen J.T., Heikkinen E., Myllylä V.V., Huikuri H.V., and Isojärvi J.I. Cardiac autonomic control in patients with refractory epilepsy before and during vagus nerve stimulation treatment: a one-year follow-up study. Epilepsia 47 (2006) 556-562
31. Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 33 (1992) 1005-1012
32. Muñana K.R., Vitek S.M., Tarver W.B., Saito M., Skeen T.M., Sharp N.J., Olby N.J., and Haglund M.M. Use of vagal nerve stimulation as a treatment for refractory epilepsy in dogs. J Am Vet Med Assoc 221 (2002) 977-983